Drug Database
Back to search

United States· US:50090-7965_13df9823-1b56-4de2-ad10-c99508180f39

Bumetanide

A bumetanide product containing bumetanide, registered in United States by A-S Medication Solutions. The same ATC class is registered in 10 of our 19 countries.

ATC C03CA02US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedBumetanideATCC03CA02REGISTER NO.US:50090-7965_13df982…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about bumetanideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Bumetanide is registered in 10 of 19 countries.

Countries holding a registration under ATC C03CA02 (bumetanide), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 5 of them publish a price we can compare per daily dose
Search bumetanide products by name

Bumetanide · ATC C03CA02

10 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Franceprice
  • Ireland
  • Netherlands
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of bumetanide costs, country by country.

Normalised to the WHO defined daily dose (1 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Bumetanide · price per daily dose (1 mg)

USD · FX 28 Sept 2026

  • FR France$0.13
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
BUMETANIDE
Manufacturer
A-S Medication Solutions
Country
United States (US)
ATC code
C03CA02
ATC class
Bumetanide
Defined daily dose
1 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    50090-7965-2
  • ndc11
    5009079652
    90 TABLET in 1 BOTTLE (50090-7965-2)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

318 interactions on record for bumetanide.

Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check bumetanide against other medicinesHow interaction checks work

Bumetanide · interactions on record

318 records

  • 15 severe
  • 177 moderate
  • 9 minor
  • 116 info

Most severe, free to view

  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • NeomycinA07AA01severe
  • StreptomycinA07AA04severe

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Bumetanide in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bumetanide products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Austria · Burinex
  • Belgium · Burinex
  • Denmark · Burinex
  • Spain · Fordiuran
  • France · Burinex
  • United Kingdom (Northern Ireland) · Bumetanide Generics Uk, Bumetanide Niche Generics
  • Greece · Burinex
  • Ireland · Burinex
  • Luxembourg · Burinex
  • Malta · Burinex
  • Netherlands · Bumetanide Cf, Bumetanide Sandoz
  • Norway · Burinex
  • Sweden · Burinex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/be985a8e-f7d5-4f02-9b38-26535574eaa3
GET /v1/drugs/be985a8e-f7d5-4f02-9b38-26535574eaa3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "1",
  "substance": "BUMETANIDE",
  "productndc": "50090-7965",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA219291",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about bumetanide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console